Clonal Ph-negative hematopoiesis in CML after therapy with imatimib mesylate is frequently characterized by trisomy 8 [1]

Leukemia

Volumn 16, Issue 7, 2002, Pages 1390-1393

  Andersen, M K ^a   Pedersen Bjergaard, J ^a   Kjeldsen, L ^a   Dufva, I H ^b   Brondum Nielsen K ^c  

^a Rigshospitalet   (Denmark)

^b Amtssygehuset Herlev ^*  (Denmark)

^c JOHN F KENNEDY INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BCR ABL PROTEIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSTATIC AGENT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GYRASE INHIBITOR; HYDROXYUREA; IMATINIB; INTERFERON; MELPHALAN; PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; BLOOD CELL; BLOOD EXAMINATION; BONE MARROW CELL; CHROMOSOME DELETION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DRUG EFFECT; FEMALE; GENE EXPRESSION PROFILING; HEMATOPOIESIS; HUMAN; HUMAN CELL; LETTER; LEUKOCYTE COUNT; MALE; MOLECULAR CLONING; MONOSOMY 7; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE EFFECT; THROMBOCYTE COUNT; TRISOMY 8;

EID: 0036051772     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402634     Document Type: Letter

References (21)

1. Chronic myeloid leukemia
2. Randomized comparison of busulfan and hydroxurea in chronic myelogeneous leukaemia: Prolongation of survival by hydroxurea
3. Randomized comparison of interferon-alpha with busulfan and hydroxurea in chronic myelogeneous leukaemia
4. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogeneous leukemia
5. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
6. Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa
7. Allogeneic bone marrow transplantation for CML: A report from the International Bone Marrow Transplant Registry
8. Trisomy 8 in Philadelphia chromosome (Ph1)-negative cells in the course of Ph1-positive chronic myelocytic leukemia
9. A second case of trisomy 8 in Philadelphia chromosome (Ph)-negative cells during the course of Ph-positive chronic myelocytic leukemia
10. Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of α-interferon therapy for Ph positive chronic myelocytic leukemia
11. Acute myeloblastic leukaemia without Philadelphia chromosome developing after interferon therapy for chronic myelocytic leukaemia with Philadelphia chromosome
12. 1-positive chronic myelogenous leukemia
13. Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases
14. Emergence of additional chromosomal abnormalities following treatment with STI571 (Imatinib Mesylate) for Philadelphia positive chronic myeloid leukemia in chronic phase
15. Non random chromosomal abnormalities in Ph-negative bone marrow (BM) cells from CML patients achieving major cytogenetic responses (MCR) with STI571 (Gleevec™)
16. Treatment with STI571 (Novartis®) in chronic myeloid leukemia (CML): Unexpected hematological findings in a series of 26 patients
17. Evidence for a multistep pathogenesis of chronic myelogeneous leukemia
18. Further evidence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia
19. Clonal B lymphocytes lack bcr rearrangement in Ph-positive chronic myelogenous leukaemia
20. Late-appearing Philadelphia chromosome in two patients with chronic myelogenous leukemia
21. Expression profiling reveals biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics